Cancer still remains one of the worst nightmares for health patients around the world that suffer from it. While lung cancer remains the leading cause of death by cancer in the United States for males, prostate cancer takes the second spot with more than 2 million deaths annually across the United States. The numbers are even higher across the globe and many male patients are now going through various medical procedures that can allow them to diagnose and treat prostate cancer in early stages so that it can be cured immediately. Prostate Specific Antigen remains one of the most popular ways to detect such cancer early when cure is possible but there are many unknown facts that are now coming to light.
According to the new study done by Harvard School of Public Health it has been revealed that going through the PSA screening has not really helped patients that suffer from prostate cancer. While PSA remains one of the widely used methods to detect prostate cancer it was found that the screening has led to spike in over-diagnosed tumors that would never harm the patient at all. This means that after the screening many patients undergo treatments that are actually not required at all which eventually leads to many other side effects like erectile dysfunction and incontinence.
This study has raised many eyebrows and questions as to whether men should go ahead with PSA screening or not to detect early signs of prostate cancer. There has been a lot of debate on this topic in the medical world as doctors and medical experts on both sides speak out their minds and vote for or against the PSA screening. There are many questions that are still unanswered as to when should men go for screening and how often should he retest and how doctors can help patients to get the right results every time.